Grant: Master's Award: Canada Graduate Scholarships
University of Toronto
$17,500.00
Exploring APOL1 genetic risk and family perspectives on clinical genetic testing in children of African ancestry with nephrotic syndrome in Ontario
EF 2022-23
Résumé
Chronic kidney disease affects 14% of people in Sub-Saharan Africa and a common cause is nephrotic syndrome in children and adults. In nephrotic syndrome, the kidneys leak proteins in the urine and cause swelling of the body, breathing problems, blood clots, and infections. Variants of the Apolipoprotein L1 (APOL1) gene have been implicated with higher rates of nephrotic syndrome and progressive chronic kidney disease in individuals of African ancestry. The role of APOL1 variants leading to higher number of relapses and poor response to treatment in those with nephrotic syndrome is unclear. Since there are novel treatments available now to treat carriers with APOL1 kidney risk variants, it is important to engage with people of African ancestry to talk about genetic testing and raise awareness of the link to kidney disease.
Using genetic information of over 700 children with nephrotic syndrome in our established study called Insight Into Nephrotic Syndrome: Investigating Genes, Health, and Therapeutics, we will study burden of APOL1 risk and its association with the number of relapses and response to treatment. We will also hold focus groups to talk about APOL1 genetic risk and perspectives on genetic screening with parents of children of African ancestry enrolled in our cohort and also engage community-based organizations. The goal is to increase awareness on genes and kidney disease among those of African ancestry. The findings from our study will refine a precision medicine approach to identify children of African ancestry at risk of kidney disease in a culturally safe manner.
Programme
Master's Award: Canada Graduate Scholarships
Bénéficiaire
Emplacement
Ontario, Canada
Type de bénéficiaire
Academia
Type
Grant
Source
CIHR Funding Decisions Database
Tel que publié
Id
486524
Name
Ahmed Ranie
Region
Ontario
Country
Canada
Orgtype
Institution Paid; Research Institution
Prcname2
Special Cases - Awards Programs
Projecttitle
Exploring APOL1 genetic risk and family perspectives on clinical genetic testing in children of African ancestry with nephrotic syndrome in Ontario
Programtype2
Studentship Programs
Orgnameinp2
University of Toronto
Cihramount2
$17,500
Cihrequipment2
$0
Programname2
Master's Award: Canada Graduate Scholarships
Keyworddelim
Focus Groups; Genetic Epidemiology; Genetics; Gwas; Nephrology; Pediatrics
Abstract
Chronic kidney disease affects 14% of people in Sub-Saharan Africa and a common cause is nephrotic syndrome in children and adults. In nephrotic syndrome, the kidneys leak proteins in the urine and cause swelling of the body, breathing problems, blood clots, and infections. Variants of the Apolipoprotein L1 (APOL1) gene have been implicated with higher rates of nephrotic syndrome and progressive chronic kidney disease in individuals of African ancestry. The role of APOL1 variants leading to higher number of relapses and poor response to treatment in those with nephrotic syndrome is unclear. Since there are novel treatments available now to treat carriers with APOL1 kidney risk variants, it is important to engage with people of African ancestry to talk about genetic testing and raise awareness of the link to kidney disease.
Using genetic information of over 700 children with nephrotic syndrome in our established study called Insight Into Nephrotic Syndrome: Investigating Genes, Health, and Therapeutics, we will study burden of APOL1 risk and its association with the number of relapses and response to treatment. We will also hold focus groups to talk about APOL1 genetic risk and perspectives on genetic screening with parents of children of African ancestry enrolled in our cohort and also engage community-based organizations. The goal is to increase awareness on genes and kidney disease among those of African ancestry. The findings from our study will refine a precision medicine approach to identify children of African ancestry at risk of kidney disease in a culturally safe manner.
Competitiondate
202212
Approvedterm2
1 yr 0 mth
Pinamesdelim
Ahmed, Ranie
Approvedterm
1 an 0 mois
Cihrcontribution2
~ $17,500~ $0~